Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Main en Main – Dr S. Ajeganova – Reumatologie from Elsene, company number BE1029008761, closed financial year 2025 with a result of € 14,529 after tax. For that financial year Main en Main – Dr S. Ajeganova – Reumatologie recorded a gross margin of € 18,331 and equity of € 17,029. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.
€ 17,029
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14,529
Profit after tax over the fiscal year.
€ 21,171
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 14,529.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 42
Loans from banks and other lenders, long and short.
€ 270
Supplier invoices still open on the last day of the fiscal year.
€ 4,744
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Main en Main – Dr S. Ajeganova – Reumatologie?
What happened at Main en Main – Dr S. Ajeganova – Reumatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 14,529. Source: NBB ↗
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
- Sofia Ajeganova became a director. NBB
In short
Paid € 3,644 in corporate taxes since 2025.
A new publication or filing at Main en Main – Dr S. Ajeganova – Reumatologie? We notify you, reason included.
Follow Main en Main – Dr S. Ajeganova – ReumatologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Main en Main – Dr S. Ajeganova – Reumatologie is Sofia Ajeganova.
Directors
According to the 2025 annual accounts
Sofia Ajeganova
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Amerikaanse straat 193
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1029.008.761
- VAT number
- BE 1029.008.761
- Registered office
- Amerikaanse straat 193, 1050 Elsene
- Names & denominations
- Main en Main – Dr S. Ajeganova – Reumatologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 October 2025
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van huisartspraktijken
Overige zakelijke dienstverlening, neg